MVL, an antiviral protein from a cyanobacterium

Details for Australian Patent Application No. 2005222381 (hide)

Owner The Government of The United States of America, as represented by The Secretary, Department of Health and Human Services

Inventors Bewley, Carole A.

Agent Griffith Hack

Pub. Number AU-B-2005222381

PCT Pub. Number WO2005/087799

Priority 60/551,058 09.03.04 US

Filing date 9 March 2005

Wipo publication date 22 September 2005

Acceptance publication date 23 December 2010

International Classifications

C07K 14/195 (2006.01) Peptides having more than 20 amino acids - from bacteria

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/087799 Priority application(s): WO2005/087799

15 February 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 12 Jan 2007

23 December 2010 Application Accepted

  Published as AU-B-2005222381

21 April 2011 Standard Patent Sealed

4 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005222384-Growth factor binding constructs materials and methods

2005222374-Access channel with constrained arrival times